139 related articles for article (PubMed ID: 21820712)
1. Immunization with modified vaccinia virus Ankara prevents eczema vaccinatum in a murine model of atopic dermatitis.
Oyoshi MK; Wang JY; Geha RS
J Allergy Clin Immunol; 2011 Oct; 128(4):890-892.e3. PubMed ID: 21820712
[TBL] [Abstract][Full Text] [Related]
2. Protective murine and human monoclonal antibodies against eczema vaccinatum.
Tomimori Y; Kawakami Y; McCausland MM; Ando T; Koriazova L; Kato S; Kawakami T; Crotty S
Antivir Ther; 2011; 16(1):67-75. PubMed ID: 21311110
[TBL] [Abstract][Full Text] [Related]
3. Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.
Achdout H; Lustig S; Israely T; Erez N; Politi B; Tamir H; Israeli O; Waner T; Melamed S; Paran N
Vaccine; 2017 Jul; 35(33):4245-4254. PubMed ID: 28625523
[TBL] [Abstract][Full Text] [Related]
4. Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.
Knitlova J; Hajkova V; Voska L; Elsterova J; Obrova B; Melkova Z
PLoS One; 2014; 9(12):e114374. PubMed ID: 25486419
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia Ig ameliorates eczema vaccinatum in a murine model of atopic dermatitis.
Oyoshi MK; Ramesh N; Geha RS
J Invest Dermatol; 2012 Apr; 132(4):1299-301. PubMed ID: 22189790
[No Abstract] [Full Text] [Related]
6. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.
Kawakami Y; Tomimori Y; Yumoto K; Hasegawa S; Ando T; Tagaya Y; Crotty S; Kawakami T
J Exp Med; 2009 Jun; 206(6):1219-25. PubMed ID: 19468065
[TBL] [Abstract][Full Text] [Related]
7. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum.
Howell MD; Jones JF; Kisich KO; Streib JE; Gallo RL; Leung DY
J Immunol; 2004 Feb; 172(3):1763-7. PubMed ID: 14734759
[TBL] [Abstract][Full Text] [Related]
8. Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation.
Scott JE; ElKhal A; Freyschmidt EJ; MacArthur DH; McDonald D; Howell MD; Leung DY; Laouar A; Manjunath N; Bianchi T; Boes M; Oettgen HC; Geha RS
J Allergy Clin Immunol; 2007 Dec; 120(6):1382-8. PubMed ID: 17889291
[TBL] [Abstract][Full Text] [Related]
9. A case of eczema vaccinatum.
Hicks R; Kost L
Ann Allergy; 1970 Oct; 28(10):491-3. PubMed ID: 5521179
[No Abstract] [Full Text] [Related]
10. [CAUSES OF GENERALIZED VACCINIA WITH ECZEMA VACCINATUM AND ITS TREATMENT WITH INACTIVATED SMALLPOX VACCINE].
EHRENGUT W
Med Welt; 1965 Apr; 17():937-9. PubMed ID: 14293912
[No Abstract] [Full Text] [Related]
11. IL-10 suppresses IL-17-mediated dermal inflammation and reduces the systemic burden of Vaccinia virus in a mouse model of eczema vaccinatum.
Darling AR; Freyschmidt EJ; Burton OT; Koleoglou KJ; Oyoshi MK; Oettgen HC
Clin Immunol; 2014 Feb; 150(2):153-60. PubMed ID: 24412909
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status.
Domenico J; Lucas JJ; Fujita M; Gelfand EW
Int Arch Allergy Immunol; 2012; 158(2):196-205. PubMed ID: 22286752
[TBL] [Abstract][Full Text] [Related]
13. Eczema vaccinatum.
Reed JL; Scott DE; Bray M
Clin Infect Dis; 2012 Mar; 54(6):832-40. PubMed ID: 22291103
[TBL] [Abstract][Full Text] [Related]
14. ECZEMA VACCINATUM.
DEWAR WA
Br Med J; 1964 Oct; 2(5416):1071. PubMed ID: 14191176
[No Abstract] [Full Text] [Related]
15. Adverse events occurring after smallpox vaccination.
Lane JM; Goldstein J
Semin Pediatr Infect Dis; 2003 Jul; 14(3):189-95. PubMed ID: 12913830
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis.
von Sonnenburg F; Perona P; Darsow U; Ring J; von Krempelhuber A; Vollmar J; Roesch S; Baedeker N; Kollaritsch H; Chaplin P
Vaccine; 2014 Sep; 32(43):5696-702. PubMed ID: 25149431
[TBL] [Abstract][Full Text] [Related]
17. [Generalized eczema vaccinatum complicating infantile eczema].
ZAHRADNIK M
Cesk Pediatr; 1956 May; 11(5):365-9. PubMed ID: 13343367
[No Abstract] [Full Text] [Related]
18. Thymic stromal lymphopoietin and IL-33 promote skin inflammation and vaccinia virus replication in a mouse model of atopic dermatitis.
Oyoshi MK; Venturelli N; Geha RS
J Allergy Clin Immunol; 2016 Jul; 138(1):283-286. PubMed ID: 26830114
[No Abstract] [Full Text] [Related]
19. Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.
Oyoshi MK; Elkhal A; Kumar L; Scott JE; Koduru S; He R; Leung DY; Howell MD; Oettgen HC; Murphy GF; Geha RS
Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14954-9. PubMed ID: 19706451
[TBL] [Abstract][Full Text] [Related]
20. Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus.
Oyoshi MK; Beaupré J; Venturelli N; Lewis CN; Iwakura Y; Geha RS
J Allergy Clin Immunol; 2015 Jun; 135(6):1511-8.e6. PubMed ID: 25649082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
